Preparing for Net ZeroHow Climate & Sustainability Will Affect Diligence in M&A Transactions
Despite its mission to improve health, the healthcare industry is responsible for some of the world’s highest carbon emissions, which aggravates chronic respiratory diseases. One study claims the pharmaceutical industry emits up to 50% more carbon than the car industry. Successful deal making is a critical enabler for most big pharma, but what impact might business development transactions have on the delivery of carbon and other sustainability targets? How might such targets affect the execution of and decision making associated with transactions?
Report Snap Shot
This report covers:
- Customers - a driving force for change
- Consequences of failing to deliver
- Due diligence in a carbon-sensitive environment